Australia News
-
Merck pays Bionomics $172mn for pain molecules
Australia | News | By BioSpectrum Bureau | 0 Comment | 01 Aug, 2013
Singapore: Bionomics entered in an agreement with Merck, which is also known as Merck Sharp and Dohme outside the US and...Read more
-
Phosphagenics gearing up to enter South East Asia
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Australian drug delivery technology company Phosphagenics will launch its TPM technology in the global raceh...Read more
-
Alchemia demerges Audeo on NASDAQ, ASX
Australia | News | By BioSpectrum Bureau | 0 Comment | 02 Jan, 2013
Singapore: Alchemia has demerged its subsidiary, Audeo Oncology, on NASDAQ and the ASX. The company has announced that i...Read more
-
FDA approves clinical trial of EndoBarrier
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: GI Dynamics has received full approval from the U.S. Food and Drug Administration (FDA) to commence a 25-site...Read more
-
AusBiotech appoints new board member
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: AusBiotech announced the appointment of Mr Lawrence Gozlan as a non-executive director, bringing to the Boar...Read more
-
FDA agrees to Mesoblast MPC supply in the US
Australia | News | By BioSpectrum Bureau | 0 Comment | 15 Feb, 2013
Singapore: Mesoblast announced that US FDA is in agreement for the supply of its proprietary Mesenchymal Precursor Cell...Read more
-
Academy discusses future of Australian science
Australia | News | By BioSpectrum Bureau | 0 Comment | 25 Sep, 2012
Singapore: The Australian Academy of Science's recently established Early-Mid Career Researcher Forum held its first nat...Read more
-
Asia vaccine strategists call for collaboration
Australia | News | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2013
Asia needs a solution, that goes beyond traditional structure, models and pathways, to meet the essential vaccine supply...Read more
-
Lose weight and treat diabetes at the same time
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 Sep, 2012
Singapore: Doctors at St Vincent's Clinic and Macquarie University Hospital (MUH) in Sydney are now offering EndoBarrier...Read more
-
Transgene out-licenses TG1042 to Ascend Pharma
Australia | News | By BioSpectrum Bureau | 0 Comment | 08 Jul, 2013
Singapore: French biotech firm Transgene SA has granted Ascend Biopharmaceuticals, an emerging privately-held Australian...Read more
-
NeuClone, Serum Institute join hands
Australia | News | By BioSpectrum Bureau | 0 Comment | 07 Jul, 2014
Singapore: Sydney-based biotechnology firm, NeuClone has signed a major licensing agreement and joint development partne...Read more
-
Victoria is on mission to tap the Indian market
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 04 Feb, 2013
Hyderabad: BioAsia 2013, which was held recently from January 28-30, 2013, at Hyderabad, India, saw participation from 5...Read more
-
Muted growth for Australia in 2011
Australia | Analysis | By Piyusha Chatterjee | 0 Comment | 29 May, 2012
Despite concerns over the operating environment in Australia and predictions of receding demand in the domestic market, ...Read more
-
New drug delivery polymer to treat cancer
Australia | News | By BioSpectrum Bureau | 0 Comment | 01 Jan, 2013
Singapore: Dr Lingxue Kong and research colleagues at Deakin University in Melbourne, Australia, have combined two polym...Read more
-
Study visualizes link between gluten and immune system
Australia | News | By BioSpectrum Bureau | 0 Comment | 12 Oct, 2012
Singapore: A link between gluten and the immune system has literally been visualized in new research published in the sc...Read more
-
Phylogica, Cubist evaluate antimicrobial phylomers
Australia | News | By BioSpectrum Bureau | 0 Comment | 26 Jul, 2013
Singapore: Phylogica is collaborating with Cubist Pharmaceuticals in order to evaluate several of its antimicrobial Phyl...Read more
-
Kevin Buchi joins Benitec board
Australia | Influencers | By BioSpectrum Bureau | 0 Comment | 11 Apr, 2013
Singapore: Benitec Biopharma appointed Mr Kevin Buchi to its board of directors. Mr Buchi served as CEO of Cephalon, thr...Read more
-
Osiris successfully defends patent challenge in Australia
Australia | Regulatory | By BioSpectrum Bureau | 0 Comment | 26 Feb, 2013
Singapore: Osiris Therapeutics, a Columbia-based company focused on developing and marketing stem cell products to treat...Read more
